Apart from that, the baseline features between patients who were with and without TACE refractory were also compared; their baseline features were almost the same, except that the AFP level was higher in HCC patients without refractory to the TACE treatment (P = 0.038, Supplementary Table 1). Here, AFP is linked to hepatocellular carcinoma.